Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arcturus Therapeutics Ltd.

13.95
+0.54004.03%
Post-market: 13.990.0400+0.29%18:50 EDT
Volume:482.04K
Turnover:6.58M
Market Cap:378.33M
PE:-5.53
High:14.01
Open:13.59
Low:13.03
Close:13.41
Loading ...

Arcturus Therapeutics Holdings Inc. to Announce Fourth Quarter 2025 Financial Results

Reuters
·
23 Jun

Citi Keeps Their Buy Rating on Arcturus Therapeutics (ARCT)

TIPRANKS
·
10 Jun

Arcturus Therapeutics Held Annual Stockholders Meeting

Reuters
·
07 Jun

Arcturus Therapeutics to Attend Upcoming Investor Conferences

Business Wire
·
30 May

Scotiabank Initiates Arcturus Therapeutics at Outperform

MT Newswires Live
·
28 May

William Blair Remains a Buy on Arcturus Therapeutics (ARCT)

TIPRANKS
·
21 May

Arcturus Therapeutics Is Maintained at Overweight by Wells Fargo

Dow Jones
·
14 May

Arcturus Therapeutics Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
13 May

Arcturus Therapeutics Holdings Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
13 May

Arcturus Therapeutics Q1 EPS $(0.52) Beats $(1.33) Estimate, Sales $29.38M Beat $27.88M Estimate

Benzinga
·
13 May

Arcturus Therapeutics Reports 22.6% Drop in Q1 Revenue, Narrows Net Loss to $14.1 Million, EPS Improves to ($0.52)

Reuters
·
13 May

BRIEF-Arcturus Therapeutics Q1 Operating Income USD -16.826 Million Vs. IBES Estimate USD -41.6 Million

Reuters
·
13 May

Arcturus Therapeutics Q1 Basic EPS USD -0.52 VS. Ibes Estimate USD -1.33

THOMSON REUTERS
·
13 May

Arcturus Therapeutics Holdings Inc: Prioritization of Mrna Therapeutics Pipeline Extends Cash Runway Into 2028

THOMSON REUTERS
·
13 May

Arcturus Therapeutics Holdings Inc: Arct-810 (Otc) Phase 2 Interim Data Expected Q2 2025

THOMSON REUTERS
·
13 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
12 May

Arcturus Therapeutics Holdings Inc expected to post a loss of $1.33 a share - Earnings Preview

Reuters
·
10 May

Earnings Preview: Arcturus Therapeutics (ARCT) Q1 Earnings Expected to Decline

Zacks
·
05 May

Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 12, 2025

THOMSON REUTERS
·
23 Apr

Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 12, 2025

Business Wire
·
23 Apr